Clinical trial
Long COVID: Cord Tissue-Derived Mesenchymal Stromal Cells for Persistent NeuroInflammatory Symptoms
NCT06156241 is registered in ClinicalTrials.gov with Charles Cox as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long COVID: Cord Tissue-Derived Mesenchymal Stromal Cells for Persistent NeuroInflammatory Symptoms
- Lead sponsor
- Charles Cox
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 31, 2024
- Completion date
- February 28, 2026
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.